Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134172) titled 'Clinical study on the use of Romiplostim N01 for the secondary prevention of thrombocytopenia caused by concurrent chemoradiotherapy in gynecological malignancies' on Oct. 11.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital
Condition:
Cervical cancer, endometrial cancer, vulvar cancer, vaginal cance
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-25
Target Sample Size: Experimental group:49;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3...